Global (United States, European Union and China) Humanized Mouse and Rat Model Market Research Report 2019-2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Humanized Mouse and Rat Model Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Genetic
- 1.3.3 Cell-Based
- 1.4 Market Segment by Application
- 1.4.1 Global Humanized Mouse and Rat Model Market Share by Application (2019-2025)
- 1.4.2 Pharmaceutical
- 1.4.3 Biotechnology Companies
- 1.4.4 CRO
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Humanized Mouse and Rat Model Production Value 2014-2025
- 2.1.2 Global Humanized Mouse and Rat Model Production 2014-2025
- 2.1.3 Global Humanized Mouse and Rat Model Capacity 2014-2025
- 2.1.4 Global Humanized Mouse and Rat Model Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Humanized Mouse and Rat Model Market Size CAGR of Key Regions
- 2.2.2 Global Humanized Mouse and Rat Model Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Humanized Mouse and Rat Model Capacity by Manufacturers
- 3.1.2 Global Humanized Mouse and Rat Model Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Humanized Mouse and Rat Model Revenue by Manufacturers (2014-2019)
- 3.2.2 Humanized Mouse and Rat Model Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Humanized Mouse and Rat Model Market Concentration Ratio (CR5 and HHI)
- 3.3 Humanized Mouse and Rat Model Price by Manufacturers
- 3.4 Key Manufacturers Humanized Mouse and Rat Model Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Humanized Mouse and Rat Model Market
- 3.6 Key Manufacturers Humanized Mouse and Rat Model Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Genetic Production and Production Value (2014-2019)
- 4.1.2 Cell-Based Production and Production Value (2014-2019)
- 4.2 Global Humanized Mouse and Rat Model Production Market Share by Type
- 4.3 Global Humanized Mouse and Rat Model Production Value Market Share by Type
- 4.4 Humanized Mouse and Rat Model Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Humanized Mouse and Rat Model Consumption by Application
6 Production by Regions
- 6.1 Global Humanized Mouse and Rat Model Production (History Data) by Regions 2014-2019
- 6.2 Global Humanized Mouse and Rat Model Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Humanized Mouse and Rat Model Production Growth Rate 2014-2019
- 6.3.2 United States Humanized Mouse and Rat Model Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Humanized Mouse and Rat Model Import & Export
- 6.4 European Union
- 6.4.1 European Union Humanized Mouse and Rat Model Production Growth Rate 2014-2019
- 6.4.2 European Union Humanized Mouse and Rat Model Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Humanized Mouse and Rat Model Import & Export
- 6.5 China
- 6.5.1 China Humanized Mouse and Rat Model Production Growth Rate 2014-2019
- 6.5.2 China Humanized Mouse and Rat Model Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Humanized Mouse and Rat Model Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Humanized Mouse and Rat Model Consumption by Regions
- 7.1 Global Humanized Mouse and Rat Model Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Humanized Mouse and Rat Model Consumption by Type
- 7.2.2 United States Humanized Mouse and Rat Model Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Humanized Mouse and Rat Model Consumption by Type
- 7.3.2 European Union Humanized Mouse and Rat Model Consumption by Application
- 7.4 China
- 7.4.1 China Humanized Mouse and Rat Model Consumption by Type
- 7.4.2 China Humanized Mouse and Rat Model Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Humanized Mouse and Rat Model Consumption by Type
- 7.5.2 Rest of World Humanized Mouse and Rat Model Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 The Jackson Laboratory (US)
- 8.1.1 The Jackson Laboratory (US) Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.1.4 Humanized Mouse and Rat Model Product Introduction
- 8.1.5 The Jackson Laboratory (US) Recent Development
- 8.2 Taconic Biosciences (US)
- 8.2.1 Taconic Biosciences (US) Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.2.4 Humanized Mouse and Rat Model Product Introduction
- 8.2.5 Taconic Biosciences (US) Recent Development
- 8.3 Horizon Discovery Group(UK)
- 8.3.1 Horizon Discovery Group(UK) Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.3.4 Humanized Mouse and Rat Model Product Introduction
- 8.3.5 Horizon Discovery Group(UK) Recent Development
- 8.4 genOway (France)
- 8.4.1 genOway (France) Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.4.4 Humanized Mouse and Rat Model Product Introduction
- 8.4.5 genOway (France) Recent Development
- 8.5 Charles River Laboratories (US)
- 8.5.1 Charles River Laboratories (US) Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.5.4 Humanized Mouse and Rat Model Product Introduction
- 8.5.5 Charles River Laboratories (US) Recent Development
- 8.6 Harbour Antibodies BV (China)
- 8.6.1 Harbour Antibodies BV (China) Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.6.4 Humanized Mouse and Rat Model Product Introduction
- 8.6.5 Harbour Antibodies BV (China) Recent Development
- 8.7 Hera BioLabs (US)
- 8.7.1 Hera BioLabs (US) Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.7.4 Humanized Mouse and Rat Model Product Introduction
- 8.7.5 Hera BioLabs (US) Recent Development
- 8.8 Vitalstar Biotechnology Co (China)
- 8.8.1 Vitalstar Biotechnology Co (China) Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.8.4 Humanized Mouse and Rat Model Product Introduction
- 8.8.5 Vitalstar Biotechnology Co (China) Recent Development
- 8.9 inGenious Targeting Laboratory (US)
- 8.9.1 inGenious Targeting Laboratory (US) Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.9.4 Humanized Mouse and Rat Model Product Introduction
- 8.9.5 inGenious Targeting Laboratory (US) Recent Development
- 8.10 AXENIS(France)
- 8.10.1 AXENIS(France) Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Humanized Mouse and Rat Model
- 8.10.4 Humanized Mouse and Rat Model Product Introduction
- 8.10.5 AXENIS(France) Recent Development
- 8.11 Crown Bioscience (US)
- 8.12 Transgenic (Japan)
- 8.13 Champions Oncology (US)
- 8.14 Horizon Discovery Group(UK)
- 8.15 Hera BioLabs (US)
- 8.16 Yecuris Corporation (US)
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Humanized Mouse and Rat Model Capacity, Production Forecast 2019-2025
- 9.1.2 Global Humanized Mouse and Rat Model Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Humanized Mouse and Rat Model Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Humanized Mouse and Rat Model Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Humanized Mouse and Rat Model Production Forecast by Type
- 9.7.2 Global Humanized Mouse and Rat Model Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Humanized Mouse and Rat Model Sales Channels
- 10.2.2 Humanized Mouse and Rat Model Distributors
- 10.3 Humanized Mouse and Rat Model Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
A "humanized" immune system rodent model is one in which human primary haematopoietic cells and tissues are implanted into an immunodeficient host that generate a functional human immune system. Humanized mice or rat model are commonly used as small animal models in biological and medical research for human therapeutics.
Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of R&D activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.
In 2019, the market size of Humanized Mouse and Rat Model is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Humanized Mouse and Rat Model.
This report studies the global market size of Humanized Mouse and Rat Model, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Humanized Mouse and Rat Model production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
The Jackson Laboratory (US)
Taconic Biosciences (US)
Horizon Discovery Group(UK)
genOway (France)
Charles River Laboratories (US)
Harbour Antibodies BV (China)
Hera BioLabs (US)
Vitalstar Biotechnology Co (China)
inGenious Targeting Laboratory (US)
AXENIS(France)
Crown Bioscience (US)
Transgenic (Japan)
Champions Oncology (US)
Horizon Discovery Group(UK)
Hera BioLabs (US)
Yecuris Corporation (US)
Market Segment by Product Type
Genetic
Cell-Based
Market Segment by Application
Pharmaceutical
Biotechnology Companies
CRO
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Humanized Mouse and Rat Model status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Humanized Mouse and Rat Model manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Humanized Mouse and Rat Model are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025